Drug recalls
432 recent drug recalls in our current data.
Showing 1–200, newest first.
FDA Not Yet Classified · Drug · October 14, 2026
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Company / brand: Centric Compounding recalls
Affected product: Tri-Immune Boost (Glutathione recall status
Official ID EVT-99860-15i85aw ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: Apothecary Pharma recalls
Affected product: Apothecary NAD+ Injection 200 mg/mL recall status
Official ID D-0037-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: Apothecary Pharma recalls
Affected product: Tirzepatide Injection recall status
Official ID D-0036-2027 ·
Official record ↗
FDA Class III · Drug · October 14, 2026
Failed Impurities/Degradation Specifications
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Tretinoin Cream UPS recall status
Official ID D-0035-2027 ·
Official record ↗
FDA Class III · Drug · October 14, 2026
Failed Impurities/Degradation Specifications
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Tretinoin Cream USP recall status
Official ID D-0034-2027 ·
Official record ↗
FDA Class III · Drug · October 14, 2026
Failed Impurities/Degradation Specifications
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Tretinoin Cream USP recall status
Official ID D-0033-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: Tri-MIX (PAPAV/PHENTO/ALPROS) recall status
Official ID D-0032-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: Tri-MIX (PAPAV/PHENTO/ALPROS) recall status
Official ID D-0031-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE recall status
Official ID D-0030-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE recall status
Official ID D-0029-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE recall status
Official ID D-0028-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE recall status
Official ID D-0027-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE recall status
Official ID D-0026-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: Tri-MIX (PAPAV/PHENTO/ALPROS) recall status
Official ID D-0025-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: Tri-MIX (PAPAV/PHENTO/ALPROS) recall status
Official ID D-0024-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: Tri-MIX (PAPAV/PHENTO/ALPROS) recall status
Official ID D-0023-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: Tri-MIX (PAPAV/PHENTO/ALPROS) recall status
Official ID D-0022-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: QUAD-MIX( PAPAV/PHENTO/ALPROS/TROP) INJECTABLE recall status
Official ID D-0021-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: SERMORELIN ACETATE 1 MG/ML INJECTABLE recall status
Official ID D-0020-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE recall status
Official ID D-0019-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: SEMAGLUTIDE 3 MG/ML INJECTABLE recall status
Official ID D-0018-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Company / brand: Carolina Infusion recalls
Affected product: TIRZEPATIDE 26 MG/ML INJECTABLE recall status
Official ID D-0017-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Presence of particulate matter.
Company / brand: J&J INNOVATIVE MEDICINE recalls
Affected product: IMAAVY (nipocalimab-aahu) Injection recall status
Official ID D-0016-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Failed Impurities/Degradation Specifications
Company / brand: Cipla USA recalls
Affected product: Fosfomycin Tromethamine Granules for Oral Solution recall status
Official ID D-0014-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Failed Content Uniformity Specifications
Company / brand: Preferred Pharmaceuticals recalls
Affected product: Lidocaine Ointment USP recall status
Official ID D-0013-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Failed stability specifications
Company / brand: BioSpectra recalls
Affected product: Biospectra Tris/Tromethamine recall status
Official ID D-0012-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Sterile High Performance Ultra Lubricating Eye Drops (Polyethylene Glycol 400 recall status
Official ID D-0009-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Sterile Eye Drops Redness Relief (Glycerin 0 recall status
Official ID D-0008-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Sterile Eye Drops recall status
Official ID D-0007-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Sterile Lubricant Dry Eye Relief Eye Drops recall status
Official ID D-0006-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Eye Drops MAXIMUM recall status
Official ID D-0005-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Sterile EYE DROPS Advanced Relief recall status
Official ID D-0004-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Sterile EYE DROPS AC (tetrahydrozoline HCl 0 recall status
Official ID D-0003-2027 ·
Official record ↗
FDA Class II · Drug · October 14, 2026
Lack of Assurance of Sterility
Company / brand: K.C. Pharmaceuticals recalls
Affected product: Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0 recall status
Official ID D-0002-2027 ·
Official record ↗
FDA Not Yet Classified · Drug · October 7, 2026
Discoloration: consumer complaints received for discolored tablets
Company / brand: Aurobindo Pharma USA recalls
Affected product: amazon recall status
Official ID EVT-99934-1f1l4x9 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Microbial contamination of topical product.
Company / brand: SV Labs Toronto recalls
Affected product: Benzoyl Peroxide Wash recall status
Official ID D-0879-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Microbial contamination of topical product.
Company / brand: SV Labs Toronto recalls
Affected product: Benzoyl Peroxide Wash recall status
Official ID D-0878-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Failed dissolution specifications.
Company / brand: Apotex recalls
Affected product: Paroxetine Extended-Release Tablets recall status
Official ID D-0877-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Crystallization
Company / brand: Par Health USA recalls
Affected product: Buprenorphine Hydrochloride recall status
Official ID D-0876-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Company / brand: TerSera Therapeutics recalls
Affected product: Zoladex (goserelin) implant recall status
Official ID D-0875-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Lack of Assurance of Sterility
Company / brand: Aurolab Trust recalls
Affected product: FOCUS PI Hypromellose 0 recall status
Official ID D-0874-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Defective Container; packets were found to be either empty or partially full.
Company / brand: Amneal Pharmaceuticals recalls
Affected product: Estradiol Gel recall status
Official ID D-0873-2026 ·
Official record ↗
FDA Class II · Drug · October 7, 2026
Failed Dissolution Specifications: below specification
Company / brand: Ajanta Pharma USA recalls
Affected product: Ranolazine Extended-Release Tablets recall status
Official ID D-0010-2027 ·
Official record ↗
FDA Not Yet Classified · Drug · September 30, 2026
Product Mix-up: 0.9% SODIUM CHLORIDE Injection, USP may potentially contain the overwrap with labeling indicating it to be 0.9% SODIUM CHLORIDE Injection, USP but the actual produc…
Company / brand: Otsuka ICU Medical recalls
Affected product: 0 recall status
Official ID EVT-99892-f8gl50 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Insight Pharmaceuticals recalls
Affected product: Clear Eyes Redness Relief recall status
Official ID D-0871-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Insight Pharmaceuticals recalls
Affected product: Clear Eyes Redness Relief recall status
Official ID D-0870-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Defective Delivery System: Possibility of no medication in the prefilled pen.
Company / brand: Amneal Pharmaceuticals of New York recalls
Affected product: Exenatide Injection recall status
Official ID D-0868-2026 ·
Official record ↗
FDA Class III · Drug · September 30, 2026
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Company / brand: Macleods Pharmaceuticals recalls
Affected product: Olanzapine Tablets recall status
Official ID D-0867-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0 recall status
Official ID D-0863-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: Lubricant Eye Drops-Cameron Pharmaceuticals recall status
Official ID D-0862-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: Major LubriFresh P recall status
Official ID D-0861-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: TRP The Relief Products* Gentle Eyes Lubricant Eye Drops recall status
Official ID D-0860-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: Reliable-1 Laboratories Lubricating Tears recall status
Official ID D-0859-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: Walgreens Lubricant Eye Drops recall status
Official ID D-0858-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: Walgreens Lubricant Eye Drops recall status
Official ID D-0857-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: Reliable -1 Laboratories recall status
Official ID D-0856-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
Lack of Assurance of Sterility
Company / brand: Sterling Pharmaceutical Services recalls
Affected product: AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0 recall status
Official ID D-0855-2026 ·
Official record ↗
FDA Class II · Drug · September 30, 2026
cGMP Deviations
Company / brand: SHANTOU Qiwei industrial Co recalls
Affected product: MENOW SUNSCREEN PRESSED POWDER SPF35 PA+++ recall status
Official ID D-0854-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Nystatin Cream recall status
Official ID EVT-99876-z42zg7 ·
Official record ↗
FDA Class I · Drug · September 23, 2026
Superpotent Drug
Company / brand: VITRUVIAS THERAPEUTICS recalls
Affected product: Thyroid Tablets recall status
Official ID D-0866-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Lack of Assurance of Sterility
Company / brand: Pfizer recalls
Affected product: Dopamine HCl Inj recall status
Official ID D-0853-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Dissolution Specifications
Company / brand: Inventia Healthcare recalls
Affected product: Chlorthalidone Tablets recall status
Official ID D-0852-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Company / brand: SUN PHARMA /TARO recalls
Affected product: Lidocaine Ointment USP recall status
Official ID D-0848-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: Safecor Health recalls
Affected product: Fluphenazine HCl Elixir recall status
Official ID D-0846-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: Safecor Health recalls
Affected product: Fluphenazine HCl Elixir recall status
Official ID D-0845-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: Safecor Health recalls
Affected product: Fluphenazine HCl Elixir recall status
Official ID D-0844-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: Safecor Health recalls
Affected product: Fluphenazine HCl Elixir recall status
Official ID D-0843-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: Safecor Health recalls
Affected product: Fluphenazine HCl Elixir recall status
Official ID D-0842-2026 ·
Official record ↗
FDA Class II · Drug · September 23, 2026
Failed Stability Specifications
Company / brand: Safecor Health recalls
Affected product: Fluphenazine HCl Elixir recall status
Official ID D-0841-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · September 16, 2026
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Company / brand: OurPharma recalls
Affected product: fentaNYL Citrate recall status
Official ID EVT-99837-1lubpwm ·
Official record ↗
FDA Class I · Drug · September 16, 2026
Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Company / brand: B BRAUN MEDICAL recalls
Affected product: 0 recall status
Official ID D-0869-2026 ·
Official record ↗
FDA Class I · Drug · September 16, 2026
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Company / brand: American Regent recalls
Affected product: Epinephrine Injection recall status
Official ID D-0865-2026 ·
Official record ↗
FDA Class II · Drug · September 16, 2026
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Company / brand: OurPharma recalls
Affected product: fentaNYL Citrate recall status
Official ID D-0864-2026 ·
Official record ↗
FDA Class I · Drug · September 16, 2026
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Company / brand: Baxter Healthcare recalls
Affected product: Dextrose Injection recall status
Official ID D-0850-2026 ·
Official record ↗
FDA Class III · Drug · September 16, 2026
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 …
Company / brand: Ajanta Pharma USA recalls
Affected product: Fluphenazine Hydrochloride Tablets recall status
Official ID D-0836-2026 ·
Official record ↗
FDA Class III · Drug · September 16, 2026
Subpotent Drug
Company / brand: ImprimisRx NJ recalls
Affected product: Povidone Iodine 1 recall status
Official ID D-0835-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · September 9, 2026
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Company / brand: Golden State Medical Supply recalls
Affected product: Prasugrel HCI recall status
Official ID EVT-99732-3aiyt7 ·
Official record ↗
FDA Class I · Drug · September 9, 2026
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Company / brand: OPTIMAL BALANCE PHARMACY recalls
Affected product: Glutathione 200 mg/mL recall status
Official ID D-0851-2026 ·
Official record ↗
FDA Class I · Drug · September 9, 2026
Presence of particulate matter: Particulates identified as fiberglass
Company / brand: Baxter Healthcare recalls
Affected product: 0 recall status
Official ID D-0849-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Company / brand: Golden State Medical Supply recalls
Affected product: Prasugrel HCI recall status
Official ID D-0847-2026 ·
Official record ↗
FDA Class III · Drug · September 9, 2026
Labeling: Label Mix-up
Company / brand: American Health Packaging recalls
Affected product: Buprenorphine Sublingual Tablets (C-III) recall status
Official ID D-0840-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Company / brand: Mylan Pharmaceuticals recalls
Affected product: Prasugrel Tablets recall status
Official ID D-0839-2026 ·
Official record ↗
FDA Class III · Drug · September 9, 2026
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Company / brand: Chiesi USA recalls
Affected product: Revcovi (elapegademase-lvlr) Injection recall status
Official ID D-0838-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Cross Contamination with Other Products
Company / brand: Sage Products recalls
Affected product: 2% Chlorhexidine Gluconate* Cloth recall status
Official ID D-0837-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Presence of Foreign Tablets/Capsules
Company / brand: Teva Pharmaceuticals USA recalls
Affected product: traZODone Hydrochloride Tablets recall status
Official ID D-0834-2026 ·
Official record ↗
FDA Class III · Drug · September 9, 2026
Failed dissolution specifications.
Company / brand: Supernus Pharmaceuticals recalls
Affected product: Trokendi XR recall status
Official ID D-0833-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Failed Dissolution Specifications
Company / brand: Mylan Pharmaceuticals recalls
Affected product: Carton label recall status
Official ID D-0830-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations: Potential contamination of raw material
Company / brand: Lexia recalls
Affected product: Broadway Joe's Pain Cream recall status
Official ID D-0829-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations: Potential contamination of raw material
Company / brand: Lexia recalls
Affected product: Broadway Joe's Pain Cream recall status
Official ID D-0828-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Company / brand: Allies Group recalls
Affected product: THE ONE SPF 50 INVISIBLE SUNSCREEN GEL recall status
Official ID D-0826-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Company / brand: Allies Group recalls
Affected product: THE ONE SPF 50 INVISIBLE SUNSCREEN GEL recall status
Official ID D-0825-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Company / brand: Allies Group recalls
Affected product: THE ONE SPF 50 INVISIBLE SUNSCREEN GEL recall status
Official ID D-0824-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Company / brand: Allies Group recalls
Affected product: THE ONE SPF 50 INVISIBLE SUNSCREEN GEL recall status
Official ID D-0823-2026 ·
Official record ↗
FDA Class III · Drug · September 9, 2026
Presence of Foreign Tablets/Capsules
Company / brand: Bionpharma recalls
Affected product: Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg recall status
Official ID D-0822-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Daptomycin recall status
Official ID D-0821-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Vancomycin Injection recall status
Official ID D-0820-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Vasopressin recall status
Official ID D-0819-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0818-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0817-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Phosphate in 0 recall status
Official ID D-0816-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0815-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Nexterone (amiodarone HCI) recall status
Official ID D-0814-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: CARDENE IV (Nicardipine Hydrochloride) in 0 recall status
Official ID D-0813-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Pantoprazole Sodium in 0 recall status
Official ID D-0812-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Vasopressin recall status
Official ID D-0811-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Dexmedetomidine Hydrochloride in 0 recall status
Official ID D-0810-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Famotidine Injection in Sodium Chloride Injection recall status
Official ID D-0809-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0808-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Daptomycin recall status
Official ID D-0807-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: MYXREDLIN recall status
Official ID D-0806-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Vancomycin Injection recall status
Official ID D-0805-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · September 2, 2026
Cross Contamination with Other Products
Company / brand: Safecor Health recalls
Affected product: Ibuprofen recall status
Official ID EVT-99666-wagogx ·
Official record ↗
FDA Class I · Drug · September 2, 2026
Presence of Particulate matter.
Company / brand: B BRAUN MEDICAL recalls
Affected product: Lactated Ringer's Injection USP recall status
Official ID D-0832-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Company / brand: Hikma Pharmaceuticals USA recalls
Affected product: Ramipril Capsules USP recall status
Official ID D-0831-2026 ·
Official record ↗
FDA Class I · Drug · September 2, 2026
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Company / brand: Fresenius Kabi USA recalls
Affected product: Tyenne (tocilizumab-aazg) Injection recall status
Official ID D-0827-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Company / brand: Apotex recalls
Affected product: Paxil CR recall status
Official ID D-0804-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Presence of particulate matter: glass and stopper piece
Company / brand: Mallinckrodt Hospital Products recalls
Affected product: Acthar Gel (repository corticotropin injection) recall status
Official ID D-0803-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
Company / brand: Church & Dwight Co recalls
Affected product: Zicam recall status
Official ID D-0790-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Failed content uniformity specifications.
Company / brand: Lupin Pharmaceuticals recalls
Affected product: Clobetasol Propionate Cream USP recall status
Official ID D-0789-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0786-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0785-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0784-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0783-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0782-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0781-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0780-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0779-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0778-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0777-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0776-2026 ·
Official record ↗
FDA Class II · Drug · September 2, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0775-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: niCARdipine Hydrochloride Injection recall status
Official ID D-0802-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Tralement (trace elements injection 4* recall status
Official ID D-0801-2026 ·
Official record ↗
FDA Class I · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Papaverine HCl Injection recall status
Official ID D-0800-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Multrys (Trace Elements Injection 4 recall status
Official ID D-0799-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Selenious Acid Injection recall status
Official ID D-0798-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: ACETYLCYSTEINE SOLUTION recall status
Official ID D-0797-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: ACETYLCYSTEINE SOLUTION recall status
Official ID D-0796-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Atropine Sulfate injection recall status
Official ID D-0795-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: AMINAOCAPROIC ACID INJECTION recall status
Official ID D-0794-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Cyanocobalamin injection USP recall status
Official ID D-0793-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Cyanocobalamin injection USP recall status
Official ID D-0792-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Nitroglycerin injection recall status
Official ID D-0791-2026 ·
Official record ↗
FDA Class I · Drug · August 26, 2026
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Company / brand: Fresenius Kabi USA recalls
Affected product: Morphine Sulfate Injection recall status
Official ID D-0788-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Failed Dissolution Specifications
Company / brand: Mylan Pharmaceuticals recalls
Affected product: Acamprosate Calcium recall status
Official ID D-0774-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
CGMP deviations: tablets with black specks.
Company / brand: Golden State Medical Supply recalls
Affected product: Carbamazepine Tablets recall status
Official ID D-0771-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Carbamazepine Tablets recall status
Official ID D-0770-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Lack of Assurance of Sterility
Company / brand: Regeneron Pharmaceuticals recalls
Affected product: Libtayo (cemiplimab-rwlc) Injection recall status
Official ID D-0767-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Company / brand: Shilpa Medicare recalls
Affected product: PEMRYDI RTU(pemetrexed injection) recall status
Official ID D-0765-2026 ·
Official record ↗
FDA Class II · Drug · August 26, 2026
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Company / brand: Shilpa Medicare recalls
Affected product: PEMRYDI RTU (pemetrexed injection) recall status
Official ID D-0764-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · August 19, 2026
Presence of Particulate Matter
Company / brand: Baxter Healthcare recalls
Affected product: Cefazolin in Dextrose recall status
Official ID EVT-99463-1krekt6 ·
Official record ↗
FDA Class I · Drug · August 19, 2026
Presence of Particulate Matter
Company / brand: Baxter Healthcare recalls
Affected product: Cefazolin in Dextrose recall status
Official ID D-0787-2026 ·
Official record ↗
FDA Class I · Drug · August 19, 2026
Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
Company / brand: Liebel-Flarsheim Company recalls
Affected product: Optiray Imaging Bulk Package-350 recall status
Official ID D-0773-2026 ·
Official record ↗
FDA Class I · Drug · August 19, 2026
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Company / brand: Victory Medical Center Pharmacy recalls
Affected product: Glutathione (MDV) recall status
Official ID D-0772-2026 ·
Official record ↗
FDA Class I · Drug · August 19, 2026
Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Company / brand: Buy-Herbal recalls
Affected product: Kian Pee Wan Capsules recall status
Official ID D-0769-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Company / brand: Heritage Pharmaceuticals recalls
Affected product: CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION recall status
Official ID D-0768-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Lack of assurance of sterility. The recall is due to potential contamination
Company / brand: Prestige Brands Holdings recalls
Affected product: CLEAR EYES Maximum Itchy Eye Relief recall status
Official ID D-0766-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP recalls
Affected product: SILDENAFIL CITRATE USP recall status
Official ID D-0763-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP recalls
Affected product: TADALAFIL USP recall status
Official ID D-0762-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP recalls
Affected product: TADALAFIL USP recall status
Official ID D-0761-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP recalls
Affected product: TADALAFIL USP recall status
Official ID D-0760-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP recalls
Affected product: SILDENAFIL CITRATE USP recall status
Official ID D-0759-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 20mg (5mg/mL) recall status
Official ID D-0757-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 10mg (5mg/mL) recall status
Official ID D-0756-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 7 recall status
Official ID D-0755-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 5mg (1mg/mL) recall status
Official ID D-0754-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 2 recall status
Official ID D-0753-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 0 recall status
Official ID D-0752-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 9mg (4 recall status
Official ID D-0751-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 4 recall status
Official ID D-0750-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 6 recall status
Official ID D-0749-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 2 recall status
Official ID D-0748-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Company / brand: Apollo Care recalls
Affected product: SEMAGLUTIDE 12 recall status
Official ID D-0747-2026 ·
Official record ↗
FDA Class II · Drug · August 19, 2026
Failed Dissolution Specifications
Company / brand: Novartis Pharmaceuticals recalls
Affected product: Diovan (valsartan) 160 mg recall status
Official ID D-0746-2026 ·
Official record ↗
FDA Class II · Drug · August 12, 2026
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Company / brand: Zydus Pharmaceuticals (USA) recalls
Affected product: Mirabegron Extended-Release Tablets recall status
Official ID D-0745-2026 ·
Official record ↗
FDA Class I · Drug · August 12, 2026
Presence of Particulate Matter; identified as stainless steel
Company / brand: Sunny Pharmtech recalls
Affected product: Cyclophosphamide for Injection recall status
Official ID D-0744-2026 ·
Official record ↗
FDA Class I · Drug · August 12, 2026
Presence of Particulate Matter; identified as stainless steel
Company / brand: Sunny Pharmtech recalls
Affected product: Cyclophosphamide for Injection recall status
Official ID D-0743-2026 ·
Official record ↗
FDA Class III · Drug · August 12, 2026
Incorrect Product Formulation
Company / brand: Central Admixture Pharmacy Services recalls
Affected product: Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag recall status
Official ID D-0740-2026 ·
Official record ↗
FDA Class II · Drug · August 12, 2026
shortfill; reports of empty capsules.
Company / brand: Aurobindo Pharma USA recalls
Affected product: Dicyclomine Hydrochloride Capsules recall status
Official ID D-0733-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · August 5, 2026
Failed impurity/degradation specification:12M Long-term Stability conditions (25 ¿2 ¿C/60 ¿5%RH), an OOS result observed in Related substance test analysis w.r.t Impurity II, Impur…
Company / brand: Ascend Laboratories recalls
Affected product: Dabigatran Etexilate Capsules recall status
Official ID EVT-99421-191x326 ·
Official record ↗
FDA Class III · Drug · August 5, 2026
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Company / brand: Ascend Laboratories recalls
Affected product: Dabigatran Etexilate Capsules recall status
Official ID D-0739-2026 ·
Official record ↗
FDA Class III · Drug · August 5, 2026
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Company / brand: Ascend Laboratories recalls
Affected product: Dabigatran Etexilate Capsules recall status
Official ID D-0738-2026 ·
Official record ↗
FDA Class III · Drug · August 5, 2026
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Company / brand: Ascend Laboratories recalls
Affected product: Dabigatran Etexilate Capsules recall status
Official ID D-0737-2026 ·
Official record ↗
FDA Class II · Drug · August 5, 2026
Presence of precipitate
Company / brand: MYLAN PHARMACEUTICALS recalls
Affected product: Mycophenolate Mofetil for Injection USP recall status
Official ID D-0734-2026 ·
Official record ↗
FDA Class II · Drug · August 5, 2026
CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
Company / brand: Glenmark Pharmaceuticals recalls
Affected product: Azelaic Acid Gel recall status
Official ID D-0731-2026 ·
Official record ↗
FDA Class II · Drug · August 5, 2026
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Company / brand: MICRO LABS USA recalls
Affected product: Dorzolamide HCl and Timolol Maleate Ophthalmic Solution recall status
Official ID D-0730-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · July 29, 2026
Due to an out-of-specification result for an unidentified impurity detected during routine stability testing.
Company / brand: Precision Dose recalls
Affected product: Glycopyrrolate Oral Solution recall status
Official ID EVT-99388-g6s9bf ·
Official record ↗
FDA Not Yet Classified · Drug · July 29, 2026
Failed Dissolution Specifications
Company / brand: Supernus Pharmaceuticals recalls
Affected product: Trokendi XR recall status
Official ID EVT-99375-1qlo6cy ·
Official record ↗
FDA Class III · Drug · July 29, 2026
Failed Dissolution Specifications
Company / brand: Supernus Pharmaceuticals recalls
Affected product: Trokendi XR recall status
Official ID D-0758-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Foreign Tablets/Capsules
Company / brand: Bionpharma recalls
Affected product: Divalproex Sodium Delayed-Release Tablets recall status
Official ID D-0742-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Failed Impurities/Degradation Specifications
Company / brand: Precision Dose recalls
Affected product: Glycopyrrolate Oral Solution recall status
Official ID D-0741-2026 ·
Official record ↗
FDA Class III · Drug · July 29, 2026
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testin…
Company / brand: Ascend Laboratories recalls
Affected product: Dabigatran etexilate Capsules recall status
Official ID D-0736-2026 ·
Official record ↗
FDA Class III · Drug · July 29, 2026
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testin…
Company / brand: Ascend Laboratories recalls
Affected product: Dabigatran etexilate Capsules recall status
Official ID D-0735-2026 ·
Official record ↗
FDA Class I · Drug · July 29, 2026
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to …
Company / brand: JB Chemicals and Pharmaceuticals recalls
Affected product: Cetirizine Hydrochloride Tablets USP 5 mg recall status
Official ID D-0732-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Particulate Matter: Hair was found in products
Company / brand: Fresenius Kabi USA recalls
Affected product: Xylocaine (lidocaine HCl Injection recall status
Official ID D-0729-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Particulate Matter: Hair was found in products
Company / brand: Fresenius Kabi USA recalls
Affected product: Xylocaine (lidocaine HCl Injection recall status
Official ID D-0728-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Particulate Matter: Hair was found in products
Company / brand: Fresenius Kabi USA recalls
Affected product: Naropin (ropivacaine hydrochloride Injection recall status
Official ID D-0727-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Particulate Matter: Hair was found in products
Company / brand: Fresenius Kabi USA recalls
Affected product: Lidocaine HCl Injection recall status
Official ID D-0726-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Particulate Matter: Hair was found in product
Company / brand: Fresenius Kabi USA recalls
Affected product: Glycopyrrolate Injection recall status
Official ID D-0725-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Company / brand: Rising Pharma Holding recalls
Affected product: Rising recall status
Official ID D-0724-2026 ·
Official record ↗
Sources last checked October 22, 2026 at 12:00 PM UTC.